Renal denervation therapy: A device based approach for HTN management

Renal denervation therapy: A device based approach for HTN management

Cardiology
A badge with ribbon in color black Point(s): 1 | An analog clock in color black 19 minutes | A black calendar with white triangle in center that has a black exclamation point in the middle 11 Nov 2022 

Overview

Hypertension (HTN) remains a principal cause of premature death worldwide. The goal of this learning activity is to provide doctors with a comprehensive review of renal denervation therapy (RDN) and its role in improving BP control in patients with HTN. Upon completing this module, participants will have a better understanding of the following aspects:

. Epidemiology and burden of HTN

. The role of RDN in managing HTN

. Current treatment options for HTN

. Guidelines and recommendations


CPD Reviewer:

Datin Prof Dr Chia Yook-Chin

Department of Medical Sciences, Sunway University

Department of Primary Care Medicine, University of Malaya


Who should participate:

• Doctors


NOTE :

Please watch the video before attempting the assessment questions.


Terms & Conditions:

Participants must obtain a minimum score of 8/10 (80%) to be awarded 1 point.

MIMS Education and MIMS Medica shall not be responsible or liable for the outcome of your CPD point


To play this video, you are required to have a media player such as Windows Media Player (PC), QuickTime (MAC) or another third party media player.


Sponsored by:

Mlogo-blue-170x80.jpg